美股市场个股详情
AMRN 阿玛琳
- 0.455
- -0.005-1.06%
收盘价 12/13 16:00 (美东)
- 0.469
- +0.014+3.01%
盘后 20:02 (美东)
1.87亿总市值-4.55市盈率TTM
0.480最高价0.446最低价150.88万股成交量0.470今开0.460昨收68.66万成交额0.39%换手率亏损市盈率(静)4.11亿总股本1.37052周最高0.35市净率1.75亿流通值0.44652周最低--股息TTM3.84亿流通股675.000历史最高--股息率TTM7.45%振幅0.446历史最低0.455平均价1股每手
关于阿玛琳公司
阿玛琳股份有限公司 是一家生物制药公司，专注于商业化和开发治疗药物以改善心血管(CV)健康并降低心血管(CV)风险。其商业化产品包括Vascepa。
公司介绍
公司代码AMRN
公司名称阿玛琳
上市日期1993/04/01
发行价格6.00
成立日期1989
CEOMr. Aaron D. Berg
所属市场纳斯达克
员工数量275
证券类型存托凭证
ADS转换比例1.0 : 1.0
年结日12-31
公司地址Iconic Offices, The Greenway,Block C Ardilaun Court, 112–114,St. Stephens Green
城市Dublin
省份都柏林
国家爱尔兰共和国
邮编2
电话353-1-6699-020
董事高管
- 姓名
- 职务
- 年薪
- Aaron D. Berg
- Director, President and Chief Executive Officer
- 244.81万
- Thomas C. Reilly
- Executive Vice President, Head of Global HR and Finance, Chief Financial Officer and Principal Accounting Officer
- 220.20万
- Dr. Steven B. Ketchum, PhD
- Executive Vice President, President, Research and Development and Chief Scientific Officer
- 235.06万
- Jonathan N. Provoost
- Executive Vice President, Chief Legal and Compliance Officer and Secretary
- 65.93万
- Peter Fishman
- Vice President and Global Controller
- --
- Dr. Odysseas D. Kostas, M.D.
- Chairman of the Board
- 65.04万
- Keith L. Horn
- Independent Director
- 63.21万
- Dr. Paul Cohen, M.D.
- Independent Director
- 62.21万
- Mark DiPaolo, Esq.
- Independent Director
- 62.10万
- Oliver O'Connor
- Independent Director
- 61.18万
- Diane E. Sullivan
- Independent Director
- 63.08万
- Patrice Bonfiglio
- Independent Director
- 62.69万
- Louis Sterling, III
- Independent Director
- 62.94万
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据